Our Cannabinoid Ingredients

High-Purity Rare and Minor Cannabinoid Isolates and Compounds

BayMedica delivers high-purity, rare, and minor cannabinoid isolates and compounds at a commercial scale, supporting product innovation and consistent supply across emerging categories.

Each compound is produced under the same GMP-aligned quality systems, ensuring purity, consistency, and regulatory readiness.

Our multi-platform approach includes plant extraction,  hemp-derived conversions, synthesis, and biosynthesis manufacturing methods, allowing flexibility in sourcing without compromising quality.

Ask for BayMedica

Our Cannabinoid Portfolio

Below are BayMedica’s high-purity cannabinoid isolates and compounds, available through our trusted distribution partners. Each is supported by batch documentation and Certificates of Analysis.

Manufacturing Method Key

PD = Highly Purified Synthesized

D = Synthesized

H = Hemp-derived

Cannabichromene (CBC)

A rare, non-intoxicating cannabinoid.

Produced through full synthesis and conversion pathways, including the use of plant-extracted CBG converted to synthesized CBC. BayMedica’s process may also utilize olivetol and citral, which are naturally occurring plant compounds, as building blocks to achieve a plant-identical molecule. Each batch is manufactured under GMP-aligned quality systems for consistency, scalability, and complete documentation support.

View Full CBC Product Details

Tetrahydrocannabivarin (THCV)

A rare cannabinoid valued for research and advanced formulation programs.

Produced through full synthesis and conversion pathways, including plant-extracted CBDV cyclized to THCV. BayMedica’s process also includes THCV-PD and THCV-D routes, all produced for consistency and batch-to-batch reliability. Each lot is traceable, third-party verified, and supported by food-grade GMP-aligned documentation.

View Full THCV Product Details

Cannabidivarin (CBDV)

A minor cannabinoid known for its structural similarity to CBD.

Produced through plant extraction and full synthesis, CBDV from BayMedica is developed under food-grade GMP-aligned quality systems to ensure purity, consistency, and traceability. Multiple consistent and reproducible production routes provide flexibility in sourcing and scalability while maintaining reliable composition and verification of quality, full documentation for every batch.

View Full CBDV Product Details

Cannabitriol (CBT)

A rare, trace cannabinoid.

Produced exclusively through full synthesis (with potential to make hemp-derived if there is sufficient interest), CBT is structurally related to CBC and can be formed as a natural degradation product, similar to how CBN derives from THC. BayMedica’s controlled synthesis process ensures precision, consistency, and verified composition across every batch under food-grade GMP-aligned quality systems.

View Full CBT Product Details

Cannabigerol (CBG)

A foundational minor cannabinoid isolate.

CBG serves as a core building block in the cannabinoid family and is provided by BayMedica from plant-extracted material under food-grade GMP-aligned conditions for consistent purity and composition. Our production routes ensure scalable supply, batch-to-batch reliability, and full testing from two independent labs for each batch.

Ask for BayMedica

Cannabicyclol (CBL)

A rare cannabinoid formed naturally as CBC ages and transforms over time.

CBL is a rare, non-intoxicating cannabinoid produced through the natural photo-oxidation and aging of CBC, valued for its chemical stability and potential antioxidant and neuroprotective properties.

Ask for Baymedica

Built on Quality Systems

All BayMedica cannabinoids are produced within a unified food-grade GMP-aligned framework that prioritizes compliance, reproducibility, and long-term supply confidence. Each ingredient is supported by a comprehensive documentation package that includes MSDS, Spec Sheets, Various Attestations, and two independent third-party Certificates of Analysis, ensuring exceptional transparency and quality for every batch.

GMP-aligned manufacturing
Batch-to-batch testing
Traceability and documentation
Two third-party COAs for every batch

Learn About Our Manufacturing Platform

Why Choose BayMedica

BayMedica’s platform-agnostic approach gives brands the flexibility to adapt as markets and regulations evolve. Whether your priorities are scalability, plant origin, or compliance in specific regions, our team can deliver the same high-purity cannabinoid through the route that best fits your business needs.

GET IN TOUCH Explore Our Platform

Wherever you buy your cannabinoid ingredients, Ask for BayMedica.

Platform-agnostic manufacturing for business continuity

High-purity cannabinoid isolates and compounds produced under food-grade GMP alignment

Consistent supply and transparent documentation

Trusted distribution network for seamless sourcing

Regulatory agility to keep you ready for tomorrow’s standards

Discover the Future of Cannabinoids

Contact BayMedica